Table.

Analysis of relationship between GB119 activation and presence of skin cancer in human skin samples

Measure	Group Examined	Regions of Interest (ROIs)	Sensitivity/Specificity	95% Confidence Interval (2-sided)
Sensitivity	All patients	90	0.989 (89/90)	0.940–1.000
	BCC only	56	1.000 (56/56)	0.936–1.000
	SCC only	34	0.971 (33/34)	0.847–1.000
Specificity	All patients	47	0.894 (42/47)	0.769–0.965
	BCC only	23	0.870 (20/23)	0.664–0.972
	SCC only	24	0.917 (22/24)	0.730–0.990

For these studies 55 patient samples were assessed. These samples included 35 BCC (N=8, MN=10, I=4, and S=8, M=5) and 20 SCC (WD=15, MD=3, PD=0, M=2) specimens. BCC – basal cell carcinoma; N – nodular, MN – micro-nodular, S – superficial, and I – infiltrative form of BCC; SCC – squamous cell carcinoma; WD – well differentiated, MD – mildly differentiated, and PD – poorly differentiated of SCC. M=mixed pathology for either BCC or SCC.